About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, May 28th, 2015

The QualityStocks
Daily Stock List


OmniComm Systems, Inc. (OMCM)

Zacks, Nebula Stocks, and Ceocast News reported previously on OmniComm Systems, Inc. (OMCM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OmniComm Systems, Inc. is a global leading provider of clinical data management technology. The Company is a foremost strategic software solutions provider to the life sciences industry. Its dedication is to helping the world's pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. OmniComm Systems is based in Fort Lauderdale, Florida.

The Company provides comprehensive solutions for clinical research with an extensive worldwide experience from more than 4,000 clinical trials. OmniComm’s services include hosting, study design and development, training, consulting services, technology transfer and transition, as well as 24 x 7 worldwide customer care.

TrialMaster is OmniComm Systems’ flagship product for Electronic Data Capture (EDC). TrialMaster is the EDC solution for Phase I - IV clinical trials. The TrialMaster Suite can perform a number of tasks that were historically seen in clinical applications external to an EDC system. TrialMaster has the most intuitive end-user experience, the most productive study design tool, flexible reporting, off-the-shelf integrations and convenient mechanisms for importing and exporting data.

OmniComm Systems’ products also include TrialOne. This is the leading proactive eSource and Early Phase site automation solution. TrialOne handles all Early Phase study needs. Furthermore, the Company’s products include IRTMaster. IRTMaster can support almost every kind of clinical study, from the simplest to the most complex.

In addition, the Company offers its Promasys product. Promasys is an integrated clinical data management and EDC system. It brings industry standard quality and efficiency to the data collection and data management in clinical trials.

Moreover, OmniComm offers OmniCloud. This product enables an organization to address e-Clinical suite challenges while creating an integrated best-in-class e-Clinical enterprise. Therefore, an organization can avoid the downside of utilizing an “all-in one” e-Clinical suite that may not have the suitable technology components for an organization’s study needs.

At the beginning of April, OmniComm Systems announced the general availability of release 4.2.1 of TrialMaster. This release provides new capabilities to capture audit trail information for electronic source data, significant productivity enhancements in the automated generation of SDTM datasets, the ability for sites in registry studies to export their own data, and greater than 100 other targeted enhancements.

OmniComm Systems, Inc. (OMCM), closed Thursday's trading session at $0.1999, up 2.51%, on 2,000 volume with 1 trade. The average volume for the last 60 days is 23,176 and the stock's 52-week low/high is $0.12/$0.31.

Encision, Inc. (ECIA)

SmallCapVoice reported previously on Encision, Inc. (ECIA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Encision, Inc. is a medical device company owning patented surgical technology, which prevents dangerous stray electrosurgical burns in minimally invasive surgery. The Company designs and markets a portfolio of high performance surgical instrumentation. This instrumentation delivers advances in patient safety with Active Electrode Monitoring (AEM) technology, surgical performance, and value to hospitals across a wide spectrum of minimally invasive surgical procedures.

Encision has its corporate headquarters in Boulder, Colorado. The Company was established in 1991 by Mr. Roger Odell and Mr. Dave Newton with the guiding principles of making laparoscopy safer for patients and improving clinical effectiveness. Encision’s shares trade on the OTC Markets Group’s OTCQB.

Encision pioneered the development and deployment of AEM technology to eliminate dangerous stray energy burns during minimally invasive procedures. The Company provides a complete line of premium laparoscopic monopolar surgical instruments with integrated AEM technology. Its AEM EndoShield™ Burn Protection System is a plug and play smart cord, which is the heart of the system and interfaces with AEM instruments, providing best of class surgical performance.

In addition, Encision offers several complementary products to improve clinical effectiveness and patient safety. These laparoscopic surgical products range from bipolar instrumentation to non-energized laparoscopic graspers and dissectors.

Yesterday, Encision announced financial results for its fiscal 2015 fourth quarter and fiscal year ended March 31, 2015. Encision posted quarterly net revenue of $2.307 million for a quarterly net loss of $349,000, or $(0.03) per share. These results compare to net revenue of $2.504 million for a net loss of $1.453 million, or $(0.14) per share, in the prior year quarter.

This net loss for the fiscal 2014 fourth quarter included product impairment charges of $1.1 million. Excluding product impairment charges, the net loss was $353,000, or $(0.03) per share, in the fiscal 2014 fourth quarter.

Encision posted fiscal year net revenue of $9.671 million for a fiscal year net loss of $1.383 million, or $(0.13) per share. These results compare to net revenue of $10.547 million for a net loss of $1.782 million, or $(0.20) per share, in the prior year fiscal year. Excluding product impairment charges, the net loss was $682,000, or $(0.08) per share, in the fiscal 2014 year.

Encision, Inc. (ECIA), closed Thursday's trading session at $0.717, even for the day. The average volume for the last 60 days is 6,907 and the stock's 52-week low/high is $0.51/$1.10.

Avra, Inc. (AVRN)

TopStockAnalysts, ProfitableTrading, Investors Alley, Insider Wealth Alert, Investopedia, Wyatt Investment Research, Penny Stocks Finder, SuperStockTips, InvestorSoup, Penny Stock Craze, Beacon Equity Research, and Stock Preacher reported recently on Avra, Inc. (AVRN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Avra, Inc. consists of a team of Bitcoin enthusiasts, technocrats, financiers and global business experts. The Company provides a range of solutions and services, which make Bitcoin acceptance easy for any business. Avra provides the software, the point-of-purchase terminals, the education, as well as ongoing payment systems. The Company is based in Greenville, South Carolina. Avra’s shares trade on the OTC Bulletin Board.

Bitcoin is a consensus network. It enables a new payment system and a completely digital money. Bitcoin is the first decentralized peer-to-peer payment network, which is powered by its users with no central authority or middlemen. Utilizing the Company’s technology, most every internet connected point-of-sale (POS) system and ATM kiosk can be integrated to accept Bitcoin and related emerging digital currencies.

Avra’s business model is divided into five distinct categories. One is AvraPay: to develop a total, turn-key and trouble-free way for merchants to accept Bitcoin as Payment. In addition, AvraPay operates as a regionalized payment solution. Anyone wanting to pay their household bills, purchase top-ups, and more, can do so from the AvraPay website using their digital wallet.

The second category is AvraATM: to promote usage and acceptance of digital currencies by way of Avra’s proposed network of ATMs. Businesses can add a constant stream of passive income to their kiosk business through installing AvraATM systems.

The third category is AvraTourism: to provide cryptocurrency payment processing solutions for merchants, including hotels and casinos. The Company provides hardware, software, education and ongoing support. Its specialty is working with hotels, casinos, and restaurants to take advantage of Bitcoin’s plentiful benefits for a business and its customers.

The fourth division is AvraNews: to provide a news portal focusing on digital currency news. AvraNews provides live reporting and in-depth analysis, legal opinions, live charts, and related industry reports.

The Company also has its fifth division, AvraSecure. It provides a complete spectrum of server security, hosting, and management services. These provide fully-managed and co-managed security solutions to meet the security and infrastructure needs of an organization. AvraSecure is a dedicated platform that provides critical security solutions to the growing digital currency industry.

AvraSecure is suited to complement all forms of technical payment infrastructure. This includes Bitcoin ATM machines, electronic wallets and related digital storage and transaction systems, and also payment gateways for Visa® and MasterCard® processing. This is while providing security and compliance requirements for KYC/AML that owner/operators will need to stay protected and remain compliant within the increasingly strict regulatory environment.

Avra, Inc. (AVRN), closed Thursday's trading session at $0.35, even for the day, on 13,214 volume with 3 trades. The average volume for the last 60 days is 11,459 and the stock's 52-week low/high is $0.1148/$2.50.

Matinas BioPharma Holdings, Inc. (MTNB)

Stock News Now and Stock News reported recently on Matinas BioPharma Holdings, Inc. (MTNB), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company that lists on the OTC Markets’ OTCQB. Established in 2011, the Company’s focus is on the development and commercialization of lipid-based prescription therapeutics for the treatment of infectious diseases and cardiovascular and metabolic conditions. An experienced management team and a Board of Directors with a history of building pharmaceutical companies lead Matinas BioPharma. The Company is based in Bedminster, New Jersey.

Matinas BioPharma’s emphasis is on creating highly differentiated, safe, and efficacious therapies using its expertise in drug formulation and development to address important unmet medical needs. Recent additions to its product pipeline, including MAT2203 and MAT2501, position Matinas BioPharma to become a leader in the safe and effective delivery of anti-infective therapies utilizing its proprietary lipid-crystal nano-particle cochleate formulations.

Recently, Matinas BioPharma Holdings announced that upon a scheduled interim review, the study's Steering Committee recommended to stop enrollment early in its first-in-human study of investigational drug MAT9001 because of the study having enrolled a sufficient number of subjects (42 to date) required to demonstrate primary and secondary endpoints.

Its first study is taking place in Canada and is a two-way crossover pharmacokinetic and pharmacodynamic (PK/PD) study of MAT9001 in comparison to an active prescription omega-3 medication comparator in subjects with high triglycerides (200-499 mg/dL).

MAT9001 is a proprietary prescription-only omega-3 fatty acid-based composition, consisting of docosa-pentaenoic acid (DPA) and other omega-3 fatty acids, which is under development for therapeutic applications with severe hypertriglyceridemia (TG>500 mg/dL) as the lead indication.

In Q4 2014, Matinas BipPharma filed an IND for MAT9001 with the Food and Drug Administration (FDA). It anticipates initiating a Phase 3 registration program pending two small studies and FDA agreement on the Phase 3 protocol. Matinas has purposely designed MAT9001 to provide a differentiated pharmacotherapy for the treatment of dyslipidemia.

Today, Matinas BioPharma announced that it will be presenting at the LD Micro Invitational that will take place June 1-3, 2015, at the Luxe Sunset Boulevard, Los Angeles, California. Mr. Roelof Rongen, President and CEO of Matinas BioPharma, will discuss the topline results from the pharmacokinetic and pharmacodynamic study of the Company's cardiovascular and metabolic product candidate MAT9001 on Tuesday, June 2, 2015, at 3:00 p.m. PDT / 6:00 p.m. EDT.

In addition, Mr. Rongen will review the clinical development strategy for MAT2203, a novel lipid-crystal nano-particle orally delivered formulation of Amphotericin B for the treatment of invasive fungal infections, and MAT2501, an early-stage program to treat gram-negative bacterial infections using an orally available formulation of Amikacin, a broad spectrum aminoglycoside.

Matinas BioPharma Holdings, Inc. (MTNB), closed Thursday's trading session at $1.04, down 1.42%, on 17,000 volume with 17 trades. The average volume for the last 60 days is 43,194 and the stock's 52-week low/high is $0.3101/$1.35.

Apolo Gold & Energy, Inc. (APLL)

Today we are highlighting Apolo Gold & Energy, Inc. (APLL), here at the QualityStocks Daily Newsletter.

Apolo Gold & Energy, Inc. pursues opportunities in the natural resource industry and will consider an investment in any other energy related business so as to create value. The Company is working toward expanding into a full-scale precious and industrial metal company.  In addition, Apolo Gold & Energy is currently reviewing opportunities in producing oil & gas assets in the United States and Canada, as well as onshore exploration projects in the African basin.

The Company incorporated in March 1997 (under the laws of the State of Nevada) as Apolo Gold, Inc., for the purpose of financing and operating precious metals concessions. It amended its articles of incorporation in May of 2005 to change the name of the Company to Apolo Gold & Energy, Inc. Its shares trade on the OTC Markets Groups OTCQB. Apolo Gold & Energy has its headquarters in Temple City, California.

Fundamentally, Apolo Gold & Energy is a resource enterprise in the business of locating, acquiring, as well as developing ore deposits and energy deposits. The Company targets early stage prospects. Where necessary, it takes advantage of its exploration funding by securing joint venture (JV) partners.

The Company has divided its’ business into two categories. One category is funding & exploitation. If a mine owner has mining permit tenements with mining rights and has completed its annual review, then Apolo Gold & Energy has interest to provide funding and bring technical & professional teams to join the operation with the mine owner as a JV operated and controlled by Apolo Gold & Energy.

The other category is the acquisition of mineral rights. Apolo Gold & Energy acquires mineral resources, including gold, silver, copper, lead, zinc and other valuable mineral resources. Mine owners provide the Company with the mineral mining permits and a detailed technical report.

Apolo then sends geological engineers to inspect the site and conduct a full due diligence. This includes interviewing the respective district’s mining departments. Apolo will examine the assessment report within two weeks. It will then decide whether it would consider acquiring the project.

Apolo Gold & Energy, Inc. (APLL), closed Thursday's trading session at $0.135, down 5.59%, on 27,600 volume with 8 trades. The average volume for the last 60 days is 5,548 and the stock's 52-week low/high is $0.09/$0.25.


The QualityStocks
Company Corner


Save The World Air, Inc. (ZERO)

The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.395, up 0.46%, on 35,350 volume with 15 trades. The stock’s average daily volume over the past 60 days is 100,094, and its 52-week low/high is $0.3401/$0.839.

Save The World Air, Inc. today offered congratulations to Pipeline Research Council International ("PRCI") on its new, state-of-the-art Technology Development Center ("TDC") in Houston, Texas, which will open on June 16, 2015. PRCI, the preeminent global collaborative research development organization of, by, and for the energy pipeline industry, will utilize the TDC for research and technology development to ensure the safety and efficacy of global pipeline infrastructure.

Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.

In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.

The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.

STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.

Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer

Save The World Air, Inc. Company Blog

Save The World Air, Inc. News:

STWA Congratulates Pipeline Research Council International on New Technology Development Center

STWA Announces Preliminary AOT(TM) Test Results From Southern Research Institute

STWA Reports 2015 First Quarter Financial Results

Pure Hospitality Solutions, Inc. (PNOW)

The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0022, up 15.79%, on 7,899,474 volume with 15 trades. The stock’s average daily volume over the past 60 days is 2,036,787, and its 52-week low/high is $0.0013/$0.5882.

Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Pure has four objectives:

1.   To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2.   Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3.   Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4.   Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Pure Hospitality Solutions, Inc. Company Blog

Pure Hospitality Solutions, Inc. News:

Pure Hospitality Solutions Teams up with Investors Hangout

Pure Hospitality Solutions Ramps Up Coding Integration

Pure Joins Sabre's $7 Billion Travel Network Family

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.06, up 33.33%, on 666 volume with 2 trades. The stock’s average daily volume over the past 60 days is 5,917, and its 52-week low/high is $0.032/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.0513, up 27.30%, on 21,311 volume with 3 trades. The stock’s average daily volume over the past 60 days is 72,314, and its 52-week low/high is $0.0403/$0.22.

Sibling Group Holdings, Inc. (SIBE), through its wholly owned subsidiary Blended Schools Network (BSN), provides benchmark-quality online curriculum for K-12 schools, including professional development for teachers, complete course authoring tools and learning management system (LMS) administration and support. Sibling is focused on market expansion and new product development to meet global demand by leveraging educational technology to improve student performance.

The education sector is experiencing significant disruption from innovations in delivery. Stakeholders now seek more effective and efficient solutions to improve student achievement while driving down overall costs.

Sibling is a roll-up, not a start-up, with an emphasis on three segments:

   Educational Technology (“Ed-tech”)

   Education Management

   Curriculum design and development

Sibling is positioning to be a leader in education transformation creating high-quality lifelong learning options for the global marketplace.

The May 2014 acquisition of BSN provides Sibling with extensive infrastructure and solid groundwork for growth in a rapidly growing industry. BSN offers 212 different online courses. The network served more than 160 school districts with more than 300,000 course enrollments last year.

IBIS Capital is forecasting 15-fold growth in the eLearning market over the next 10 years. The firm has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever experienced in the media industry. With a strong, highly experienced management team, Sibling is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling Groups Blended Schools Network Powers Mountain House High Schools Personalized Learning; BSN Curriculum Achieves California A-G Certification

Sibling Group's Urban Planet Mobile Deepens Strategic Partnership With Imagine Easy Solutions and EasyBib; UPMs Writing Planet Essay Scoring Solution to Be Offered Across All Imagine Easy Citation Websites Worldwide

Strategic Partner Shenzhen Times Increases Stake in Sibling Group; $5,500,000 Warrant Exercise to Fund Growth Initiatives

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.1248, up 13.45%, on 81,800 volume with 14 trades. The stock’s average daily volume over the past 60 days is 38,100, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement with Houston-Galveston Area Council

Cleartronic, Inc. (CLRI) on the "Your Monies Worth" Show

Cleartronic, Inc. (CLRI) to Be Featured on National Radio Show And Web-TV


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



INO.com Market Report




First Penny Picks

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251